Clinical Trial Update: Single Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of BDM-2 in Healthy Male Subjects. [Phase 1]

View source ↗

Summary

Phase 1 single ascending dose study assessing safety, tolerability, and pharmacokinetics of BDM-2 in healthy male subjects completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Individuals

Drugs mentioned

• BDM-2 (BDM-2)

Snippet

Sponsor: Hivih | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2020-06-17